Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
ft., today announced its fiscal third quarter 2023 financial and operating results for the three- and nine-month periods ended May 31, 2023.
- ft., today announced its fiscal third quarter 2023 financial and operating results for the three- and nine-month periods ended May 31, 2023.
- Net revenues increased by 22% QoQ, from $13 million in Q2 2023 to $15.9 million in Q3 2023.
- Net income of $2.9 million, a 107% improvement compared to $1.4 million of net income for Q3 2022.
- Free cash flow increased by 68% QoQ, from $1.9 million in Q2 2023 to $3.2 million in Q3 2023.